LYCOS RETRIEVER Beta Retriever Home  |  What is Lycos Retriever?   
Arthritis: Patients
built 633 days ago
Rheumatoid arthritis (RA) is one of the most common causes of disability in the Western world. New data released today show that rheumatoid arthritis (RA) patients treated with Abbott's HUMIRA(TM) (adalimumab) stayed working longer, had fewer absences and reported greater improvements in work performance. Results from three studies were presented today at the European League Against Rheumatism (EULAR) annual congress in Barcelona. [click link for full article] ...more
Source:
Most newly-diagnosed rheumatoid arthritis patients have questions about how severe the disease will become and what they can expect for the future. They are anxious to know the prognosis associated with rheumatoid arthritis and what factors affect the prognosis. Patients ask:
There are many options in the field of arthritis care today. With a better understanding of combination treatments, newer medications and physicians leading the way with aggressive treatment plans, arthritis patients today have hope.
Wondering if you have Arthritis?  Learn more about Arthritis in the links below. If you or someone you love battles joint pain, stiffness, and/or inflammation, arthritis pain may be the cause. There are over 100 types of arthritis and rheumatic diseases including osteoarthritis, rheumatoid arthritis, and fibromyalgia. All About Arthritis provides the latest arthritis information including the treatment options available for patients and caregivers.
Many arthritis books promise cures. Sufferers often go from one book to another without finding relief. This medical guide gives arthritis patients what they need – real, substantive information on arthritis from a source that is trusted by people all over the world - Cleveland Clinic.
Findings reported at EULAR 2007, the Annual European Congress of Rheumatology (EULAR) in Barcelona, Spain, reveal a treatment disparity between female and male patients with rheumatoid arthritis (RA). Data from a study at the Karolinska Institute, Sweden, show that women receive anti-TNFs (very effective but expensive modern medications against this disease) at a higher perceived level of disease activity and when they are reporting more severe pain than their male counterparts. [click link for full article] ...more
Source:
SEARCH
MORE ABOUT